Admission to AIM

Ideagen PLC

("Ideagen" or the "Company")

Admission to AIM

The Board of Ideagen PLC (AIM: IDEA) is pleased to announce the admission today of the Company's ordinary shares ("Ordinary Shares") to trading on the AIM Market of the London Stock Exchange ("AIM").

Ideagen is a supplier of 'Compliance Based Enterprise Information Management Software' with operations in the United Kingdom and the United States serving a number of sectors. The Group has grown both organically and through acquisition and is joining AIM in order to support the Group's strategy to become a leading supplier of Compliance Based Enterprise Information Management Software solutions to the UK in general and to the US healthcare market in particular.

finnCap are Nominated Advisor and Broker to the Company. Further information on the Company, including the Admission document and AIM Rule 26 information, is detailed on the Company's website, www.ideagenplc.com

David Hornsby, CEO of Ideagen, commented: "I am delighted Ideagen has joined AIM to support the Company's next phase of growth and provide improved liquidity in the Company's shares for both existing and new investors. I would like to thank our shareholders for their support while we were traded on PLUS SX and look forward to the future with confidence."

Enquiries:

Ideagen Plc Tel: 01438 347110

David Hornsby, Chief Executive

Graeme Spenceley, Finance Director

finnCap Limited Tel: 020 7220 0500

Marc Young/Ben Thompson (corporate finance)

Stephen Norcross (corporate broking)